-+ 0.00%
-+ 0.00%
-+ 0.00%

ESTRELLA IMMUNOPHARMA HIGHLIGHTS ARTEMIS® T-CELL THERAPY DATA SELECTED FOR ASH 2026, DEMONSTRATING DEEP AND DURABLE LEUKEMIA RESPONSES AND SUPERIOR EXTRAMEDULLARY DISEASE CLEARANCE VERSUS CONVENTIONAL CAR-T IN PRECLINICAL MODELS

Reuters·11/16/2026 13:00:00

Please log in to view news